Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Saegis Continues Cogniceutical Progress with ADHD Focus | Main | Molecules for the Mind - Tapping Into the Booming Neuropharma Market (April 19th) »

March 24, 2005

Numenta for Neurotechnology - Now That's Valuable

Email This Entry

Posted by Zack Lynch

Jeff Hawkin's has started an "On Intelligence" company Numenta to apply neuroscience to computing problems. Numenta's business focus will be the development of software tools, support services, and the licensing of intellectual property. While products are still distant, let's hope Jeff provides this new platform technology an minimal cost to neuroinformatics groups, researchers and Paul Allen's Brain Atlas team to help accelerate the development of better tools for brain disorders that directly impact one out of every four people.

Comments (0) + TrackBacks (0) | Category: Neurodiagnostics



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives